Business Wire IndiaThe Research Society for The Study of Diabetic in India (RSSDI)Wellthy Therapeuticsa digital therapeutics company focused on improving diabetes care and outcomes throughArtificial Intelligencevirtual clinical assistant
Wellthy Therapeutics and RSSDI, will work together toDEVELOP and DEPLOY CARE PROTOCOLS and GUIDELINES for lifestyle and behavioural modifications for diabetes patients in Indiaand to enable real time decision support for doctorsMr. Abhishek Shah, Co-founder & CEO, Wellthy Therapeutics“On India’s 70th Independence year, we take the pledge to help 70 million diabetics by enabling 24/7 continual care for them. Using artificial Intelligence and smartphone applications to enhance a doctor’s practice, we make lifestyle modification prescribable to every patient, and continual everyday diabetes care affordable and accessible to the vast majority of India. We are excited to announce our one of a kind partnership with the RSSDI, to empower every doctor’s practice in India, and to collaborate on landmark research initiatives to help all healthcare stakeholders in their quest to control diabetes.”Dr. Sarita Bajaj, President RSSDI (2016-17)“Behavioural change in diabetes focused on lifestyle modification, coupled with enabling affordable continued care are powerful weapons to fight and control diabetes in India. The Wellthy Therapeutics user friendly mobile application using artificial intelligence aspires to empower doctors with the ability to prescribe diabetes care. Things that a doctor always wanted to do in terms of interaction and education to patients now seems possible and readily available. It may just be the prescription required to help patients manage their day-to-day problems related to diabetes.”Dr. S R Aravind, PastPresidentRSSDI (2015-16)said,“Diabetes in India has grown into a pandemic over the last decade. Even with the most dedicated effort, our doctors and care providers have not been able to provide much needed lifestyle coaching and continual care that is core to successful diabetes management. A scalable and effective tool like ‘Wellthy Diabetes’ is now available to every doctor in India to support their efforts and make continual care a reality in India. This is a landmark innovation and I am happy RSSDI has armed itself with an effective weapon in the war against diabetes.”  Dr. S V Madhu,PastPresident RSSDI(2014-15)“RSSDI has been doing a lot of research on Diabetes management in India since a long time. However, for the first time through this, we will be able to get more meaningful insights into the patient's diabetes journey outside of clinical settings, understand their lifestyle and behavioral pattern closely and incorporate them in our care protocols. What is even more exciting is the scale at which these studies will be conducted. The combined power of Wellthy’s Technological prowess back by RSSDI’s cutting edge clinical guidelines will provide our doctors with a powerful tool to achieve better outcomes and happier healthier patients.”About Wellthy TherapeuticsAbout RSSDI:Research Society for the Study of Diabetes in India (RSSDI), founded in 1972, is the largest organisation of diabetes health care professionals and researchers in Asia. Currently, it has more than 5500 life members are represented from 29 Indian States and Union Territories. RSSDI is actively involved in updating the knowledge and skills of physicians. Each chapter carries out independent activities including CMEs for member physicians, local research grants, and awareness programs for public as well as diabetes patients. . Photo Caption: Video Caption: